New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesia

/PRNewswire/ -- Photocure ASA, The Bladder Cancer Company, announces the publication of first results from the Laser III clinical study in the medical journal,...

Related Keywords

Norway ,Australia ,United States ,New Zealand ,Denmark ,Israel ,China ,Oslo ,Chile ,Canada ,American ,Gregersg Hermann ,Erik Dahl ,Dan Schneider ,David Moskowitz ,Cysview Hexvix ,Herlev Gentofte ,Hexvix Cysview ,Corporate Communications Norway ,Bladder Cancer Company ,American Cancer Society ,Oslo Stock Exchange ,Capital Region ,European Urology ,Lead Investigator ,Consultant Urologist ,American Cancer ,Blue Light Cystoscopy ,Photocure ,